Precision Optics Corporation, Inc. POCI
Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Precision Optics Corporation, Inc. (NASDAQ: POCI) is a U.S.-based medical technology and optics company that designs, develops, manufactures, and assembles advanced optical imaging systems and components primarily for minimally invasive medical applications. The company operates in the medical device and precision optics industries, with a focus on endoscopy, micro-optics, digital imaging, and optical engineering solutions. Its products are used by original equipment manufacturers (OEMs), defense-related customers, and medical device companies seeking customized optical systems for diagnostic and surgical procedures.
The company’s primary revenue drivers include custom optical assemblies, medical imaging systems, and engineering services tied to product development and manufacturing. Precision Optics has developed capabilities in ultra-small endoscopic imaging systems, single-use endoscopes, and precision optical components that support minimally invasive procedures. Founded in 1982 and headquartered in Gardner, Massachusetts, the company evolved from a precision optics manufacturer into a specialized medical imaging supplier with vertically integrated design, prototyping, and production capabilities. Public filings and investor materials indicate that the company’s strategic positioning is based on miniaturization expertise, proprietary optical technologies, and long-standing OEM customer relationships.
Business Operations
Precision Optics conducts operations primarily through its medical optics and imaging business, serving healthcare, defense, and industrial markets. The company generates revenue through the design and manufacture of custom optical systems, imaging modules, and endoscopic visualization products. Its offerings include micro-optics, relay lenses, fiber-optic assemblies, camera systems, and digital visualization technologies used in minimally invasive surgical devices and diagnostic equipment. The company also provides engineering and contract manufacturing services for customers requiring specialized optical integration.
Operations are centered in the United States, though the company serves customers globally through OEM partnerships and international distribution channels. Precision Optics controls several core technologies involving optical design, image transmission, illumination systems, and precision manufacturing processes. Public disclosures reference strategic customer relationships with medical device developers and healthcare technology firms, particularly in the disposable and reusable endoscope markets. The company has also emphasized internal manufacturing capabilities and vertically integrated production processes as operational advantages supporting quality control and product customization.
Strategic Position & Investments
Precision Optics has focused its strategic direction on expanding its presence in minimally invasive imaging and single-use endoscopy technologies. Company filings and investor communications identify growth initiatives tied to disposable endoscope adoption, digital imaging integration, and OEM partnerships in emerging surgical applications. Management has also highlighted investments in manufacturing scale, engineering talent, and product development capabilities intended to support long-term medical device demand trends.
The company has pursued investments in advanced imaging platforms and miniaturized optical systems designed for next-generation medical devices. Precision Optics has also expanded cleanroom and manufacturing infrastructure to support higher production volumes and customer-specific programs. While the company remains relatively small compared with major medical technology competitors, its niche specialization in micro-optics and custom imaging systems has positioned it within growing sectors of the medical imaging market. Data regarding material acquisitions or large-scale portfolio holdings is limited in publicly available filings, and no major diversified subsidiary structure has been consistently identified across available public sources.
Geographic Footprint
Precision Optics is headquartered in Gardner, Massachusetts, and conducts the majority of its manufacturing, engineering, and administrative operations within the United States. The company primarily serves North American medical device customers, though its products and technologies are integrated into systems distributed internationally through OEM partners and medical technology companies.
The company’s market exposure extends into North America, Europe, and select Asia-Pacific markets through customer relationships in the global medical device industry. Public disclosures indicate that international demand is driven largely by endoscopic and minimally invasive surgical markets rather than direct consumer distribution. Precision Optics maintains a comparatively focused geographic footprint relative to multinational medical technology companies but participates in globally distributed healthcare supply chains through its OEM-oriented business model.
Leadership & Governance
Precision Optics is led by an executive team with experience in medical devices, optical engineering, manufacturing, and healthcare technology commercialization. Company strategy has emphasized innovation in minimally invasive imaging, disciplined operational execution, and expansion of OEM medical partnerships. Governance oversight is provided through the company’s board of directors and executive leadership structure disclosed in annual filings and investor materials.
Key executives identified in recent public disclosures include:
- Joseph Forkey – Chairman and Chief Executive Officer
- Daniel J. Rooney – Chief Financial Officer
- Matthew Dwyer – Chief Operating Officer
Leadership communications in SEC filings and investor presentations consistently emphasize long-term growth in medical imaging technologies, operational scalability, and continued investment in proprietary optical capabilities. Publicly available information supports the company’s strategic focus on high-precision medical optics and customized imaging solutions for minimally invasive healthcare applications.